"Mr. Lu, not only Borche Technology is supported by Luo Sheng, but Huachang Technology, another medical equipment provider that is also attracting attention today, also has Luo Sheng's capital background in it."

"What do you say? Damn, this is! ”

When the VC manager surnamed Lu heard the secretary's words, he was stunned for a while and couldn't help but burst into foul language.

This news is both good news and bad news for other venture capital institutions, the good news is that Luo Sheng is optimistic about its bright future, and the bad news is that it is difficult to get a piece of the pie directly.

With the limelight at the medical expo, the attention of these two newly founded technology companies quickly rose, especially Borche Technology, and Chen Xinhe's company's information was soon further exposed.

Don't need to be too troublesome, open the mobile phone "Tianyan Check" APP can find some key information, it didn't cause such a big movement before because of the lack of attention, and there was no big news, lack of flashpoints.

One piece of information that has undoubtedly attracted attention is that Luo Sheng's name is prominently in it, he is an angel investor in these two technology companies, and he invests in his personal name.

People from the outside world inexplicably have a feeling of sudden realization, no wonder it is so showy, it turns out that there is Luo Sheng's support.

In today's technology world, the name "Luo Sheng" has unparalleled magic, as long as the name or the institution behind the name favored startups or entrepreneurs can quickly become the darling of capital.

……

"I'm sorry, Huachang Technology currently has no financing plan, and has an agreement with Mr. Luo to only accept Mr. Luo's exclusive investment, unless he voluntarily gives up financing or he agrees to a third-party venture capital institution to come in."

"I'm sorry Manager Lu, Borche Technology currently has no plans for external financing......"

About half an hour later, the major VCs who heard the news all went to the booth behind the scenes to meet Chen Xin and Chao Junhui respectively, with the purpose and direct, wanting to invest in their companies.

But without exception, they were all rejected, which made the people of the major venture capital institutions very uncomfortable, if it was an ordinary entrepreneur and start-up company, this was a shameless face, and there were ways and means to make it succumb to the pressure of capital.

But these two can't do it, with the name Luo Sheng as its backing, no one dares to do this, in terms of the strength of capital, there is currently no venture capital institution in the world that can beat Luo Sheng in terms of capital strength.

Such a result makes many VC institutions feel like crying without tears, and suddenly they are ecstatic because they find the baby, which seems to be at their fingertips, but they find that it has nothing to do with themselves.

Don't mention worrying about it.

Why do these promising start-ups have Luo Sheng's shadow? This makes many VC institutions feel extremely unhappy, but also have to admire, as the legend of the first person in the contemporary technology industry is indeed worthy of the name.

After politely turning down the VC person who came to talk to him, Chen Xin's assistant walked over with an ieP tablet and handed it to him.

"Mr. Chen, Mr. Luo sent you two emails."

Chen Xin took the tablet, clicked on the list of unread emails, and handed it back to his assistant in a short time, and without thinking too much, he directly ordered: "Just do what is above, get it done as soon as possible, the sooner the better." ”

"Mr. Chen, but Mr. Luo didn't pay us, this batch of equipment is very expensive, and some of it has to be purchased in Europe."

Hearing this, Chen Xin wanted to reprimand his assistant, but he held back and said, "Then use the company's account liquidity first, are you still worried that the boss will cheat me for this money?" There are not a thousand or no less than eight hundred people who want to do things for the boss, and he trusts and respects me by entrusting me to do it, and knows what to do? ”

Don't look at Chen Xin as a young post-90s generation who is a bit of an anti-authority, but he is also a very sensible master, with a smart brain and a high level of double business.

And his assistant is not an elm head, as soon as he heard this, he suddenly realized, and nodded again and again: "Understood, I will deal with it myself immediately." ”

Chen Xin's words, his assistant also quickly heard the taste of a pun, and now this matter is handled by himself, which is also his trust and respect.

If you can't even realize this, then don't even think about climbing up in the future.

On the other hand, Cao Junhui also received the news, and did not neglect this matter, and immediately arranged this matter.

Moreover, this is not an ordinary errand, there are intangible benefits in it, which shows that the relationship with Luo Sheng is different from that of other founders.

The relationship is a very wonderful thing, everyone in the business market is a human spirit, and they can judge a lot of valuable information from some seemingly casual little things.

In this real society, doing something a lot of times depends on the people cooking.

With Huachang Technology and Borche Technology making a name for themselves on the first day of the Medical Expo, and spreading rapidly in the industry, in addition to the product itself being excellent enough, especially with the blessing of Luo Sheng's magical aura, the influence of this name has once again been perfectly interpreted.

All of a sudden, two new-faced companies have become the biggest winners of the Medical Expo, fame and fortune, fame and fortune, fame has gone out, will the profit be far away?

Sure enough, customer orders were already on the way, and in the afternoon of the same day, 10 hospitals and distributors who had obtained medical device business licenses came to Borche Technology to place orders, and directly placed orders for 50,000 arm or leg prostheses in one go, which was 2.25 billion yuan.

However, what is interesting is that Chen Xin has a special additional clause in the contract, that is, the partner can only earn a maximum of 15% of the profit, and the cooperation will be terminated if the profit is exceeded.

At present, although Borche Technology can supply the market with medical device business qualifications, its production capacity cannot be improved, and its own sales channel network has not been established.

This order has already wrapped up the company's production capacity this year, and according to this trend, the next market phenomenon of short supply of this product will occur.

After all, it is 10 times lower than other prosthetic products on the market, and at the same time, it is a flash in performance, so you can imagine how competitive this is.

Due to the lack of supply, it will inevitably lead to the price being raised by the market, and the middleman will earn the difference, which obviously violates Chen Xin's original intention of starting a business, and his short-term coping strategy is also simple and rude, if the price is raised, he will not supply.

The reason for this willfulness is that so far, Borche Technology's unparalleled competitiveness is the only one who can supply the market.

However, Chen Xin also knows that it is impossible to fundamentally prevent products from being speculated and thus making large profits in the middle, because this violates the basic logic of economic activities.

Middlemen always have a way of inflating their profits.

If you really want to reduce the price, only by increasing the production capacity is the fundamental way to solve the problem, in addition to establishing your own sales channel network, Chen Xin decided to learn from the marketing model of offline direct stores on the Cote d'Azur.

When the production capacity goes up and its own sales channels are established, the price will naturally come down.

On the same day, 42 major customers of pharmaceutical companies at home and abroad came to the door to place orders to purchase their "organ simulator" equipment, which can even be said to be scrambling.

This equipment has great benefits and significance for biopharmaceutical research and development, and no device can simulate the entire circulatory metabolism process of the human body before the drug enters the clinical stage, and can only be tested with mice.

Obviously, guinea pigs are not rigorous enough, and using volunteers can be extremely risky.

However, with this set of equipment to assist in the research and development of new drugs, it is different, the cost and cost of trial and error are greatly reduced, and the risk of clinical trials is greatly reduced, and the efficiency of research and development is improved at the same time, because large-scale experiments can be carried out boldly and boldly, and the efficiency of new drug research and development will of course be improved.

This set of equipment is not cheap, the price of a single set is as high as 12.2 million US dollars, but domestic and foreign pharmaceutical companies are still scrambling to grab orders after learning about this medical equipment, the reason is that a slow step may delay the research and development progress of their own pharmaceutical companies, and because Huachang Technology was established not long ago, the production capacity is definitely not for a while, so it is even more necessary to grab orders.

Although it is not cheap, it is trivial for these large pharmaceutical companies, such as Roche and Novartis, which invest tens of billions of dollars in R&D every year.

Huachang Technology signed a total of 105 sets of purchase order contracts with a total value of 1.28 billion US dollars on the same day, becoming the biggest winner of the medical expo, which surprised everyone.

VC institutions that want to invest are now dead, and they have already begun to make a big profit, so don't think about financing or anything.

The 42 pharmaceutical companies purchased this time are all well-known in the world, and dozens of international pharmaceutical companies such as Roche, Novartis, Pfizer, and Johnson & Johnson have become customers of Huachang Technology.

It is worth mentioning that from the dozens of pharmaceutical companies that have placed orders, it can also be seen that the strength of domestic pharmaceutical companies is still lagging behind, and in the list of customers for purchase orders, the top 30 global pharmaceutical companies are all listed, while none of the domestic pharmaceutical companies are on this list.

There is no doubt that the level of biopharmaceuticals is one of the important indicators to measure a country's comprehensive national strength, and it is an important area related to the national economy and people's livelihood, especially the outbreak of public health emergencies, which is of irreplaceable importance.

This year, according to the latest ranking of global pharmaceutical companies released by the North American "Pharmaceutical Manager" magazine, the top 10 pharmaceutical companies in North and Central America include 5, 2 in Switzerland, 1 in France, and 1 in Ben.

There are only four major pharmaceutical companies in China, which are also ranked 37th, 42nd, 43rd and 48th in the global pharmaceutical company rankings.

In the field of medical technology, there is obviously still a long way to go, and this time Huachang Technology shined, attracting the top 30 global pharmaceutical companies to rush to purchase its medical equipment, which can be said to not only earn a lot of money for themselves, but also to earn face for this medical expo, which is undoubtedly a great boost to the development of the domestic medical industry.

Although the domestic pharmaceutical companies are not as good as the world's top 30, Huachang Technology gives priority to supplying several domestic pharmaceutical companies, and the number of equipment is four sets, but the international pharmaceutical companies that are not bad for money are not only lining up behind, but also only supplying two sets at present, and it is not possible to increase the price and quantity.

The major international pharmaceutical companies are very dissatisfied with this, but they can only endure it, who makes Huachang Technology the only equipment provider in the world that can produce and manufacture a complete set of human metabolic cycle simulation?

Pharmaceutical companies engaged in the field of biopharmaceuticals know best what the significance of this product has for the development of clinical medicine.

……